Ureteral catheterization for uterine cancer

2021 ◽  
Vol 20 (8) ◽  
pp. 875-876
Author(s):  
B. Tarlo
Keyword(s):  
Uterine Cervix ◽  
Uterine Cancer ◽  
Ureteral Catheterization

Analyzing the issue of the treatment of inoperable uterine cervix cancers with the danger of uremia, Holz (Zentr f. Gyn., 1924, No. 13) does not agree with HoIzbach, who proposed, in order to avoid uremia due to compression of the ureters by tumor masses, their preventive preparation.

scholarly journals Original Article. Urinary Tract Desobstruction in Patients with Malignant Neoplasms of the Uterine Cervix

2016 ◽  
Vol 9 (2) ◽  
pp. 149-153
Author(s):  
Nikolay H. Kolev ◽  
Alexander Vanov ◽  
Vladislav R. Dunev ◽  
Rumen P. Kotsev ◽  
Boyan A. Stoykov ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Uterine Cervix ◽  
Urinary Tract Obstruction ◽  
Uterine Cancer ◽  
Upper Urinary Tract ◽  
University Hospital ◽  
Malignant Neoplasms ◽  
External Compression ◽  
Stent Type ◽  
First Choice

Summary Cancer of the cervix causes internal, external compression or both of the upper urinary tract in 50-60%of patients in advanced stages. Retrograde stenting is the most widely used technique for desobstruction of the upper urinary tract in urology practice. Diversion of urine flow is an alternative, achieved by nephrostomy of one or both kidneys.We studied retrospectively 33 women with upper urinary tract obstruction caused by carcinoma of the uterine cervix operated on between March 2014 and March 2015 in the urology clinic at the University Hospital in Pleven, Bulgaria. Apercutaneous nephrostomy (PNS) was placed in 17 patients, and 11 patients hadaretrograde catheterization with ureteral stent type JJ. Five patients were treated with both methods. Placement ofa JJstent was the first choice procedure for all patients since it providesabetter quality of life. PNSimproves renal function faster than retrograde JJstenting. Therefore, the first method of choice for patients with an untreated primary cervical, uterine cancer is the placement of PNS. Retrograde JJstenting is the method of choice in patients who undergo surgery and radiation therapy withoutarelapse of the disease.

scholarly journals Four cases of metastatic uterine cancer. With discussion of patients with malignant cells originating in extrauterine organs detected by uterine cervix and endometrial smears.

1994 ◽  
Vol 33 (4) ◽  
pp. 679-686
Author(s):  
Hisamori KATO ◽  
Kenji NISHINAKA ◽  
Tsuneo NAKAZAWA ◽  
Hiroki NAKAYAMA ◽  
Hiroyuki OKAJIMA ◽  
...  
Keyword(s):  
Uterine Cervix ◽  
Uterine Cancer ◽  
Malignant Cells

scholarly journals Small-Cell Carcinoma of the Uterine Cervix Discovered With Quadriplegia Caused by Cervical Spine Metastasis

2020 ◽  
Vol 13 ◽  
pp. 117954762092017
Author(s):  
Tomoko Oishi ◽  
Masakazu Nishida ◽  
Kanetoshi Takebayashi ◽  
Kaei Nasu ◽  
Hisashi Narahara
Keyword(s):  
Palliative Care ◽  
Cervical Spine ◽  
Cell Carcinoma ◽  
Small Cell Carcinoma ◽  
Uterine Cervix ◽  
Uterine Cancer ◽  
Performance Status ◽  
Small Cell ◽  
Spine Tumor ◽  
Cervical Spine Tumor

Small-cell carcinoma of the uterine cervix is a rare and aggressive tumor, and the prognosis is poor compared with those of squamous cell carcinoma and adenocarcinoma of the uterine cervix, even when discovered at an earlier stage. We treated a patient with progressive small-cell carcinoma of the uterine cervix that metastasized to the cervical spine. The patient, a 73-year-old woman, presented with the symptom of numbness in her limbs. As she had difficulty moving her limbs (ie, quadriplegia), she was carried to an emergency room. A metastatic cervical spine tumor from the uterine cervical cancer was revealed by a computed tomography scan, and the patient was then transferred to our hospital’s neurosurgery department for treatment. We performed a resection of the cervical spine tumor and fixation of the spinal bone. Because the patient’s performance status was 4 and she remained bedridden 24 h/day, we could not perform systemic chemotherapy. We thus provided palliative care, including palliative radiotherapy, pain control, and rehabilitation to improve her limbs’ functioning. The patient died of the uterine cancer within approx. 6 months after the initiation of treatment. There is no established treatment for small-cell carcinoma as a gynecological lesion. For patients with progressive uterine cancer, the optimal treatments, including palliative care, must be determined.

scholarly journals ABOUT THE ARTICLE OF DOCTOR MIRONOV “TO THE QUESTION OF INDICATIONS FOR PARTIAL CERVICAL AMPUTATION IN CANCER OF THE VAGINAL UTERINE”

2020 ◽  
Vol 6 (1) ◽  
pp. 65-73
Author(s):  
Dm. Ott
Keyword(s):  
Uterine Cervix ◽  
Statistical Data ◽  
Uterine Cancer ◽  
Critical Assessment ◽  
Cervical Amputation

In the above-published article of Dr. Mironov, the author wishes, mainly by means of statistical data, to justify the suitability of cutting off the uterine cervix alone, instead of completely removing the entire organ, for the purpose of radically curing patients with uterine cancer. Without going into a critical assessment of all the arguments that the author uses to convince the reader of this, in this note I will focus mainly on only the coverage that the author gives to the published cases and the results obtained.

Computed tomography of iliopsoas involvement in uterine cervix cancer

1987 ◽  
Vol 23 (6) ◽  
pp. 1038
Author(s):  
J U Chung ◽  
B I Choi ◽  
S H Kim ◽  
M C Han ◽  
C W Kim
Keyword(s):  
Computed Tomography ◽  
Uterine Cervix ◽  
Cervix Cancer ◽  
Uterine Cervix Cancer

THE PITUITARY AND ADRENAL RESPONSES TO ADMINISTRATION OF OESTRIOL IN GONADECTOMIZED RATS

1961 ◽  
Vol 38 (1) ◽  
pp. 50-58 ◽  
Author(s):  
N. E. Borglin ◽  
L. Bjersing
Keyword(s):  
Pituitary Gland ◽  
Adrenal Cortex ◽  
Clinical Experience ◽  
Uterine Cervix ◽  
Morphological Changes ◽  
Physiological Significance ◽  
Female Rats ◽  
Experimental Conditions ◽  
Male And Female ◽  
Male And Female Rats

ABSTRACT Oestriol (oestra-1,3,5(10)-triene-3,16α,17β-triol) is a weakly oestrogenic substance which, however, in contrast to what was formerly believed, is of physiological significance. Its effect is localized largely to the uterine cervix and vagina. Clinical experience argues both for and against an effect on the pituitary gland. This investigation is concerned with the morphological changes in the pituitary gland and adrenal cortex of gonadectomized male and female rats after the injection of oestriol. It was found that oestriol has the same type of action on these glands as other oestrogens, but under the experimental conditions used, this effect proved much weaker than that produced by oestradiol (oestra-1,3,5(10)-triene-3,17β-diol).

PROPRANOLOL-BLOCKADE OF VASOPRESSIN INDUCED INCREASE IN PLASMA PROGESTERONE IN EARLY HUMAN PREGNANCY

1971 ◽  
Vol 66 (2) ◽  
pp. 283-288 ◽  
Author(s):  
Petter Fylling
Keyword(s):  
Cyclic Amp ◽  
Uterine Cervix ◽  
Adenosine Monophosphate ◽  
First Trimester ◽  
Blocking Agent ◽  
Simultaneous Administration ◽  
Plasma Progesterone ◽  
Human Pregnancy ◽  
Peripheral Plasma ◽  
Early Human

ABSTRACT Following continuous dilation of the uterine cervix or intravenous infusion of vasopressin during the first trimester of human pregnancy, a marked increase in the peripheral plasma progesterone levels was observed. This effect was blocked by simultaneous administration of propranolol (Inderal®), a β-blocking agent. It is suggested that both these stimulating and inhibiting effects might be related to 3′, 5′-adenosine monophosphate (cyclic AMP). The results indicate the existence of β-receptors in steroid producing tissues.

Sign in / Sign up

Export Citation Format

Share Document